MEDCHRONICLE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDCHRONICLE
Largest movements
- Cash -€39,236
down €39,236 (-57.8%), from €67,857 to €28,621
mainly Contributions, distributions and other (-€70,000) and Deferred charges and accrued income (-€123)
- Receivables within one year -€13,701
down €13,701 (-73.2%), from €18,714 to €5,013
of which Trade receivables: -€7,539
- Reserves -€69,059
down €69,059 (-98.5%), from €70,083 to €1,023
- Other debts +€8,167
new in 2025: €8,167
- Trade debts +€8,078
up €8,078 (+77.9%), from €10,367 to €18,445
- Gross operating margin -€5,437
down €5,437 (-84.7%), from €6,420 to €983
- Other operating charges -€247
down €247 (-58.0%), from €426 to €179
- Financial income +€123
up €123 (+157.7%), from €78 to €201
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €86,649 | €33,835 | -€52,814 | -61.0% |
| Current assets | 29/58 | €86,649 | €33,835 | -€52,814 | -61.0% |
| Amounts receivable within one year | 40/41 | €18,714 | €5,013 | -€13,701 | -73.2% |
| Trade receivables | 40 | €9,046 | €1,507 | -€7,539 | -83.3% |
| Other amounts receivable | 41 | €9,668 | €3,505 | -€6,163 | -63.7% |
| Cash at bank and in hand | 54/58 | €67,857 | €28,621 | -€39,236 | -57.8% |
| Deferred charges and accrued income | 490/1 | €78 | €201 | +€123 | +157.7% |
| Total equity and liabilities | 10/49 | €86,649 | €33,835 | -€52,814 | -61.0% |
| Equity | 10/15 | €76,283 | €7,223 | -€69,059 | -90.5% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €70,083 | €1,023 | -€69,059 | -98.5% |
| Distributable reserves | 133 | €70,083 | €1,023 | -€69,059 | -98.5% |
| Amounts payable | 17/49 | €10,367 | €26,612 | +€16,245 | +156.7% |
| Amounts payable within one year | 42/48 | €10,367 | €26,612 | +€16,245 | +156.7% |
| Trade debts | 44 | €10,367 | €18,445 | +€8,078 | +77.9% |
| Suppliers | 440/4 | €10,367 | €18,445 | +€8,078 | +77.9% |
| Other amounts payable | 47/48 | - | €8,167 | +€8,167 | |
| Other operating charges | 640/8 | €426 | €179 | -€247 | -58.0% |
| Gross operating margin | 9900 | €6,420 | €983 | -€5,437 | -84.7% |
| Operating profit (loss) | 9901 | €5,993 | €804 | -€5,190 | -86.6% |
| Financial income | 75/76B | €78 | €201 | +€123 | +157.7% |
| Recurring financial income | 75 | €78 | €201 | +€123 | +157.7% |
| Financial charges | 65/66B | €56 | €64 | +€8 | +13.8% |
| Recurring financial charges | 65 | €56 | €64 | +€8 | +13.8% |
| Profit (loss) for the period before taxes | 9903 | €6,015 | €941 | -€5,074 | -84.4% |
| Profit (loss) for the period | 9904 | €6,015 | €941 | -€5,074 | -84.4% |
| Profit (loss) for the period to be appropriated | 9905 | €6,015 | €941 | -€5,074 | -84.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.